Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada
Description
The treatment pattern and outcomes in patients with indolent B-cell lymphoma treated during the coronavirus disease 2019 (COVID-19) pandemic period compared to the prepandemic period are unclear. This was a retrospective population-based study using